Phibro Animal Health PAHC
NASDAQ PAHC
$37.24 +1.37 (+3.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Phibro Animal Health (PAHC) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Phibro Animal Health (PAHC) posted Return on Capital Employed [ROCE] of 16.81% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 6.24 percentage points from 10.56% a year earlier and up 1.07 percentage points from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Phibro Animal Health's Return on Capital Employed [ROCE] came in at 17.44%, up 4.86 percentage points from FY2025.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +5.90 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Phibro Animal Health's Return on Capital Employed [ROCE] was 12.58% in FY2025 (+5.68 pp), 6.90% in FY2024 (-2.36 pp), 9.26% in FY2023 (-2.09 pp) and 11.35% in FY2022 (-0.19 pp).
  • The fiscal Q4 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since fiscal Q3 2019.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last eight quarters, with an average year-over-year change of +3.99 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was fiscal Q3 2026, with a gain of 6.54 percentage points; the weakest was fiscal Q1 2024, with a drop of 2.95 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior fiscal quarters was 15.74% (Q3 2026), 15.17% (Q2 2026) and 13.06% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Phibro Animal Health 1.51 Bn 1.19 Bn 134.40 Mn 16.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.81%
Mar 31, 2026 15.74%
Dec 31, 2025 15.17%
Sep 30, 2025 13.06%
Jun 30, 2025 10.56%
Mar 31, 2025 9.20%
Dec 31, 2024 9.14%
Sep 30, 2024 9.00%
Jun 30, 2024 6.87%
Mar 31, 2024 7.46%
Dec 31, 2023 7.34%
Sep 30, 2023 7.22%
Jun 30, 2023 9.07%
Mar 31, 2023 8.89%
Dec 31, 2022 9.09%
Sep 30, 2022 10.17%
Jun 30, 2022 10.77%
Mar 31, 2022 10.82%
Dec 31, 2021 11.27%
Sep 30, 2021 10.76%
API Access

Phibro Animal Health Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PAHC&period=max&api_key=YOUR_API_KEY